help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olleros, M. L.
Right arrow Articles by Garcia, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olleros, M. L.
Right arrow Articles by Garcia, I.
(American Journal of Pathology. 2005;166:1109-1120.)
© 2005 American Society for Investigative Pathology

Contribution of Transmembrane Tumor Necrosis Factor to Host Defense against Mycobacterium bovis Bacillus Calmette-Guerin and Mycobacterium tuberculosis Infections

Maria L. Olleros*, Reto Guler*, Dominique Vesin*, Roumen Parapanov*, Gilles Marchal{dagger}, Eduardo Martinez-Soria*, Nadia Corazza{ddagger}, Jean-Claude Pache*, Christoph Mueller{ddagger} and Irene Garcia*

From the Department of Pathology and Immunology,* University of Geneva, Geneva, Switzerland; the Department of Pathology,{ddagger} University of Bern, Bern, Switzerland; and the Laboratoire du Bacillus Calmette-Guerin and Unité de Physiopathologie de l’Infection,{dagger} Institut Pasteur, Paris, France

To study the specific role of transmembrane tumor necrosis factor (TmTNF) in host defense mechanisms against bacillus Calmette-Guerin (BCG) and Mycobacterium tuberculosis infections, we compared the immune responses of TNF/lymphotoxin (LT)-{alpha}–/– mice expressing a noncleavable transgenic TmTNF (TmTNF tg) to those of TNF/LT-{alpha}–/– and wild-type mice. Susceptibility of TNF/LT-{alpha}–/– mice to BCG infection was associated with impaired induction of systemic RANTES but not of monocyte chemoattractant protein 1 (MCP-1), the development of excessive local and systemic Th1-type immune responses, and a substantially reduced inducible nitric oxide synthase (iNOS) activity. Resistance of TmTNF tg mice to BCG infection was associated with efficient activation of iNOS in granulomas and with the regulated release of local and systemic chemokines and Th1-type cytokines. However, M. tuberculosis infection of TmTNF tg mice resulted in longer survival and enhanced resistance compared to TNF/LT-{alpha}–/– mice but higher sensitivity than wild-type mice. TmTNF tg mice exhibited reduced pulmonary iNOS expression and showed an exacerbated cellular infiltration in the lungs despite a modest bacillary content. Our data thus indicate a role for TmTNF in host defense against mycobacteria by contributing to induction and regulation of Th1-type cytokine and chemokine expression leading to development of bactericidal granulomas expressing iNOS, which critically determines susceptibility versus resistance of the host to mycobacterial infections.





This article has been cited by other articles:


Home page
J. Immunol.Home page
S. C. Cowley, J. D. Sedgwick, and K. L. Elkins
Differential Requirements by CD4+ and CD8+ T Cells for Soluble and Membrane TNF in Control of Francisella tularensis Live Vaccine Strain Intramacrophage Growth
J. Immunol., December 1, 2007; 179(11): 7709 - 7719.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Zalevsky, T. Secher, S. A. Ezhevsky, L. Janot, P. M. Steed, C. O'Brien, A. Eivazi, J. Kung, D.-H. T. Nguyen, S. K. Doberstein, et al.
Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to Infection
J. Immunol., August 1, 2007; 179(3): 1872 - 1883.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Uchiyama, I. Kawamura, T. Fujimura, M. Kawanishi, K. Tsuchiya, T. Tominaga, T. Kaku, Y. Fukasawa, S. Sakai, T. Nomura, et al.
Involvement of Caspase-9 in the Inhibition of Necrosis of RAW 264 Cells Infected with Mycobacterium tuberculosis
Infect. Immun., June 1, 2007; 75(6): 2894 - 2902.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Spohn, R. Guler, P. Johansen, I. Keller, M. Jacobs, M. Beck, F. Rohner, M. Bauer, K. Dietmeier, T. M. Kundig, et al.
A Virus-Like Particle-Based Vaccine Selectively Targeting Soluble TNF-{alpha} Protects from Arthritis without Inducing Reactivation of Latent Tuberculosis
J. Immunol., June 1, 2007; 178(11): 7450 - 7457.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. O'Kane, J. J. Boyle, D. E. Horncastle, P. T. Elkington, and J. S. Friedland
Monocyte-Dependent Fibroblast CXCL8 Secretion Occurs in Tuberculosis and Limits Survival of Mycobacteria within Macrophages
J. Immunol., March 15, 2007; 178(6): 3767 - 3776.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. K. McCoy, T. N. Martinez, K. A. Ruhn, D. E. Szymkowski, C. G. Smith, B. R. Botterman, K. E. Tansey, and M. G. Tansey
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
J. Neurosci., September 13, 2006; 26(37): 9365 - 9375.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Musicki, H. Briscoe, S. Tran, W. J. Britton, and B. M. Saunders
Differential Requirements for Soluble and Transmembrane Tumor Necrosis Factor in the Immunological Control of Primary and Secondary Listeria monocytogenes Infection.
Infect. Immun., June 1, 2006; 74(6): 3180 - 3189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Torres, L. Janot, V. F.J. Quesniaux, S. I. Grivennikov, I. Maillet, J. D. Sedgwick, B. Ryffel, and F. Erard
Membrane Tumor Necrosis Factor Confers Partial Protection to Listeria Infection
Am. J. Pathol., December 1, 2005; 167(6): 1677 - 1687.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.